ELISA Protocol for Covid-19 IgG Antibody Detection
Independently validated early results have proven 100% in specificity after testing 280 samples and 100% sensitivity by testing 260 samples of recovered and symptomatic patients.
Independently validated early results have proven 100% in specificity after testing 280 samples and 100% sensitivity by testing 260 samples of recovered and symptomatic patients.
The Omnipath Combi SARS-CoV-2 IgG ELISA detects and quantifies antibodies against the coronavirus and increases the University of Oxford’s testing capacity to up to 50,000 tests per day.
The 10-minute assay is performed with a saliva sample, sample diluent, and a single VeraPrep-based assay reagent.
The Bill and Melinda Gates Foundation has granted the partners $885,000 to develop an advanced rapid diagnostic for onchocerciasis.
Engineered recombinant antibodies offer advantages over serum-based controls.
SeptiCyte Rapid distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about 1 hour.